If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Aiko Nagayama is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 103 Citations
  • 5 h-Index
  • 9 Article
  • 5 Review article
  • 1 Letter

Impact of neoadjuvant and adjuvant chemotherapy on invasive lobular carcinoma: A propensity score-matched analysis of SEER data

Watanuki, R., Hayashida, T., Yokoe, T., Kawai, Y., Kikuchi, M., Nakashoji, A., Nagayama, A., Seki, T., Takahashi, M. & Kitagawa, Y., 2020 Sep 1, In : Breast Journal. 26, 9, p. 1765-1770 6 p.

Research output: Contribution to journalArticle

  • 1 Citation (Scopus)

    Novel antibody–drug conjugates for triple negative breast cancer

    Nagayama, A., Vidula, N., Ellisen, L. & Bardia, A., 2020, In : Therapeutic Advances in Medical Oncology. 12

    Research output: Contribution to journalReview article

    Open Access
  • 1 Citation (Scopus)

    Clinical significance of evaluating hormone receptor and HER2 protein using cell block against metastatic breast cancer: A multi-institutional study

    Matsui, A., Murata, Y., Masuda, N., Mori, K., Takahashi, M., Yamashiro, K., Aogi, K., Maeda, S., Itou, M., Ozaki, S., Kuraoka, K., Satou, Y., Ichihara, S., Tokunaga, E., Taguchi, K., Watanabe, T., Suzuki, H., Nagayama, A. & Nishimura, R., 2019, In : Oncotarget. 10, 55, p. 5680-5689 10 p.

    Research output: Contribution to journalArticle

    Open Access
  • Effectiveness of Antiemetic Regimens for Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Network Meta-Analysis

    Yokoe, T., Hayashida, T., Nagayama, A., Nakashoji, A., Maeda, H., Seki, T., Takahashi, M., Takano, T., Abe, T. & Kitagawa, Y., 2019 Jun, In : Oncologist. 24, 6, p. e347-e357

    Research output: Contribution to journalReview article

  • 3 Citations (Scopus)

    Sacituzumab for the treatment of triple-negative breast cancer: the poster child of future therapy?

    Zangardi, M. L., Spring, L. M., Nagayama, A. & Bardia, A., 2019 Feb 1, In : Expert Opinion on Investigational Drugs. 28, 2, p. 107-112 6 p.

    Research output: Contribution to journalArticle